05/24/2026
Don’t miss today’s session, and don’t forget to register to receive the accredited hours certificate after the session ends.
Don’t miss today’s session, and don’t forget to register to receive the accredited hours certificate after the session ends.
https://cmetracker.net/ULOU/Publisher?page=pubOpen&fbclid=IwY2xjawR_xbBleHRuA2FlbQIxMABicmlkETFCdk5Scm1ucHh4d1Q5YVdBc3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHtd-l3A5BEtT-9e3rutwL80AWtWQrARvjUpxsMpusFz3j41r92-RPg76_n1h_aem_4wZmpoSP2XVI-dT60mop_w #/getCertificate
🎯 Join us for a focused, case-based discussion:
🧠 Relapse Post-Allo in Ph+ AML: An End or a New Beginning?
We’ll explore:
• The significance of BCR-ABL positivity in defining high-risk AML and guiding TKI integration
• The critical role of molecular surveillance and donor chimerism monitoring after allo-HSCT
• How early post-transplant relapse can still be approached with curative intent
• Salvage strategies using FLAG-based reinduction, TKIs, and second allo-HSCT
• The evolving role of Dasatinib post-transplant and the ongoing debate regarding optimal TKI duration
• Clinical decision-making in young fit patients with molecular relapse after transplant
This educational board is designed for medical students, residents, interns, and physicians interested in hematology, oncology, and transplant medicine, offering practical insights through real-world clinical discussion and evolving evidence-based management.
📅 Date: May 24, 2026
⏰ Time: 9:00 PM Cairo Time | 2:00 PM EST
Don’t miss this engaging discussion on one of the most challenging and evolving areas in leukemia management.
🎟️ Register now and join us online
https://www.eventbrite.com/e/relapse-post-allo-in-ph-aml-an-end-or-a-new-beginning-tickets-1989151797573?aff=oddtdtcreator
